2.2.0.25falsefalse42001 - Disclosure - Quarterly Results of Operations (Details)truefalseIn Thousands, except Per Share datafalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010 USD ($) USD ($) / shares $Duration_10_1_2010_To_12_31_20102http://www.sec.gov/CIK0000882095duration2010-10-01T00:00:002010-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2falsefalseUSDfalsefalse7/1/2010 - 9/30/2010 USD ($) USD ($) / shares $Duration_7_1_2010_To_9_30_2010http://www.sec.gov/CIK0000882095duration2010-07-01T00:00:002010-09-30T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3falsefalseUSDfalsefalse4/1/2010 - 6/30/2010 USD ($) USD ($) / shares $Duration_4_1_2010_To_6_30_2010http://www.sec.gov/CIK0000882095duration2010-04-01T00:00:002010-06-30T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4falsefalseUSDfalsefalse1/1/2010 - 3/31/2010 USD ($) USD ($) / shares $Duration_1_1_2010_To_3_31_2010http://www.sec.gov/CIK0000882095duration2010-01-01T00:00:002010-03-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$5falsefalseUSDfalsefalse10/1/2009 - 12/31/2009 USD ($) / shares USD ($) $Duration_10_1_2009_To_12_31_2009http://www.sec.gov/CIK0000882095duration2009-10-01T00:00:002009-12-31T00:00:00Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6falsefalseUSDfalsefalse7/1/2009 - 9/30/2009 USD ($) USD ($) / shares $Duration_7_1_2009_To_9_30_2009http://www.sec.gov/CIK0000882095duration2009-07-01T00:00:002009-09-30T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$7falsefalseUSDfalsefalse4/1/2009 - 6/30/2009 USD ($) USD ($) / shares $Duration_4_1_2009_To_6_30_2009http://www.sec.gov/CIK0000882095duration2009-04-01T00:00:002009-06-30T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$8falsefalseUSDfalsefalse1/1/2009 - 3/31/2009 USD ($) USD ($) / shares $Duration_1_1_2009_To_3_31_20092http://www.sec.gov/CIK0000882095duration2009-01-01T00:00:002009-03-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$9falsefalseUSDfalsefalse1/1/2010 - 12/31/2010 USD ($) USD ($) / shares $Duration_1_1_2010_To_12_31_2010http://www.sec.gov/CIK0000882095duration2010-01-01T00:00:002010-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$10falsefalseUSDfalsefalse1/1/2009 - 12/31/2009 USD ($) USD ($) / shares $Duration_1_1_2009_To_12_31_2009http://www.sec.gov/CIK0000882095duration2009-01-01T00:00:002009-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$11falsefalseUSDfalsefalse1/1/2008 - 12/31/2008 USD ($) USD ($) / shares $Duration_1_1_2008_To_12_31_2008http://www.sec.gov/CIK0000882095duration2008-01-01T00:00:002008-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0us-gaap_QuarterlyFinancialDataAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalse3false0us-gaap_Revenuesus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse19986870001998687[1]falsetruefalsefalsefalse2truefalsefalse19376560001937656[1]falsetruefalsefalsefalse3truefalsefalse19272240001927224[1]falsetruefalsefalsefalse4truefalsefalse20858530002085853[1]falsetruefalsefalsefalse5truefalsefalse20323790002032379falsetruefalsefalsefalse6truefalsefalse18013890001801389falsetruefalsefalsefalse7truefalsefalse16471550001647155falsetruefalsefalsefalse8truefalsefalse15304600001530460falsetruefalsefalsefalse9truefalsefalse79494200007949420falsetruefalsefalsefalse10truefalsefalse70113830007011383falsetruefalsefalsefalse11truefalsefalse53357500005335750falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse4false0us-gaap_GrossProfitus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse14339010001433901[1]falsefalsefalsefalsefalse2truefalsefalse13879750001387975[1]falsefalsefalsefalsefalse3truefalsefalse13505360001350536[1]falsefalsefalsefalsefalse4truefalsefalse13476330001347633[1]falsefalsefalsefalsefalse5truefalsefalse13309990001330999falsefalsefalsefalsefalse6truefalsefalse12392550001239255falsefalsefalsefalsefalse7truefalsefalse11853330001185333falsefalsefalsefalsefalse8truefalsefalse11181660001118166falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.No authoritative reference available.falsefalse5false0us-gaap_ProfitLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse626365000626365[1]falsefalsefalsefalsefalse2truefalsefalse702163000702163[1]falsefalsefalsefalsefalse3truefalsefalse709127000709127[1]falsefalsefalsefalsefalse4truefalsefalse852094000852094[1]falsefalsefalsefalsefalse5truefalsefalse799393000799393falsefalsefalsefalsefalse6truefalsefalse670478000670478falsefalsefalsefalsefalse7truefalsefalse569145000569145falsefalsefalsefalsefalse8truefalsefalse586576000586576falsefalsefalsefalsefalse9truefalsefalse28897490002889749falsefalsefalsefalsefalse10truefalsefalse26255920002625592falsefalsefalsefalsefalse11truefalsefalse19703350001970335falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A1, A4, A5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 5 -Subparagraph b Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(1) falsefalse6false0us-gaap_NetIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse629419000629419[1]falsefalsefalsefalsefalse2truefalsefalse704876000704876[1]falsefalsefalsefalsefalse3truefalsefalse712061000712061[1]falsefalsefalsefalsefalse4truefalsefalse854901000854901[1]falsefalsefalsefalsefalse5truefalsefalse802212000802212falsefalsefalsefalsefalse6truefalsefalse673033000673033falsefalsefalsefalsefalse7truefalsefalse571398000571398falsefalsefalsefalsefalse8truefalsefalse589112000589112falsefalsefalsefalsefalse9truefalsefalse29012570002901257falsefalsefalsefalsefalse10truefalsefalse26357550002635755falsefalsefalsefalsefalse11truefalsefalse19788990001978899falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 falsefalse7false0us-gaap_EarningsPerShareBasicus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse0.780.78[1]falsetruefalsefalsefalse2truefalsefalse0.850.85[1]falsetruefalsefalsefalse3truefalsefalse0.810.81[1]falsetruefalsefalsefalse4truefalsefalse0.950.95[1]falsetruefalsefalsefalse5truefalsefalse0.890.89falsetruefalsefalsefalse6truefalsefalse0.750.75falsetruefalsefalsefalse7truefalsefalse0.630.63falsetruefalsefalsefalse8truefalsefalse0.650.65falsetruefalsefalsefalse9truefalsefalse3.393.39falsetruefalsefalsefalse10truefalsefalse2.912.91falsetruefalsefalsefalse11truefalsefalse2.152.15falsetruefalsefalsefalseEPSus-types:perShareItemTypedecimalThe amount of net income or loss for the period per each share of common stock outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 36, 37, 38 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 falsetrue8false0us-gaap_EarningsPerShareDilutedus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse0.760.76[1]falsetruefalsefalsefalse2truefalsefalse0.830.83[1]falsetruefalsefalsefalse3truefalsefalse0.790.79[1]falsetruefalsefalsefalse4truefalsefalse0.920.92[1]falsetruefalsefalsefalse5truefalsefalse0.870.87falsetruefalsefalsefalse6truefalsefalse0.720.72falsetruefalsefalsefalse7truefalsefalse0.610.61falsetruefalsefalsefalse8truefalsefalse0.630.63falsetruefalsefalsefalse9truefalsefalse3.323.32falsetruefalsefalsefalse10truefalsefalse2.822.82falsetruefalsefalsefalse11truefalsefalse2.062.06falsetruefalsefalsefalseEPSus-types:perShareItemTypedecimalThe amount of net income or loss for the period per each share of common stock and dilutive common stock equivalents outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 11, 12, 36 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 falsetrue9false0us-gaap_AssetImpairmentChargesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse136000000136000falsetruefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 45, 46, 47 falsefalse1During 2010, we recorded $136.0 million of impairment charges in R&D expense, related to certain IPR&D assets acquired from CV Therapeutics. See Notes 5 and 9. 118Quarterly Results of Operations (Details) (USD $)ThousandsUnKnownNoRoundingUnKnownfalsetrue